Evaluation of efficacy and safety of oral voriconazole in the management of recalcitrant and recurrent dermatophytosis. B S C, D S P. Clin Exp Dermatol 2022;47:30-36.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

B S C, D S P. Evaluation of efficacy and safety of oral voriconazole in the management of recalcitrant and recurrent dermatophytosis. Clin Exp Dermatol 2022;47:30-36.
PMID: 34115896